EUVIMEDEUVIMED entdecken
Leserbrief

Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide

Ahmet Oruç iD, Mustafa Erol iD

Journal of Clinical Oncology · 10.11.2026 · 44 (32) · 3176-3177

DOI: 10.1200/jco-26-00962 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.11.2026. Verfasst von Ahmet Oruç und 1 weiteren Autor:innen. Beteiligte Einrichtung: Ahmet Oruç, MD, Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey, Mustafa Erol, MD; and Department of Nuclear Medicine, Ne…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Ahmet Oruç, MD, Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey, Mustafa Erol, MD; and Department of Nuclear Medicine, Necmettin Erbakan University, Konya, Turkey.

ORCID-Profile: Ahmet Oruç, Mustafa Erol

Zitieren

APA

Oruç, A., & Erol, M. (2026). Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide. Journal of Clinical Oncology, 44(32), 3176-3177. https://doi.org/10.1200/jco-26-00962

Vancouver

Oruç A, Erol M. Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide. Journal of Clinical Oncology. 2026;44(32):3176-3177. doi:10.1200/jco-26-00962

BibTeX
@article{Oru2026,
  author = {Oruç, Ahmet and Erol, Mustafa},
  title = {Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide},
  journal = {Journal of Clinical Oncology},
  year = {2026},
  volume = {44},
  number = {32},
  pages = {3176--3177},
  doi = {10.1200/jco-26-00962}
}
Kostenlos starten →